PetMed Express shareholders approve 850K-share 2024 Omnibus Incentive Plan; director comp amended

PETMED EXPRESS INC

Shareholders approved 2024 Omnibus Incentive Plan reserving 850,000 shares (plus prior plan shares) for equity grants.
Board amended non-employee director comp program; annual RSU awards now under the Plan; total director comp capped at $750,000 per fiscal year.
All six director nominees (Campbell, Campos, Fulgoni, Mennen, Purcel, Solivan) elected with majority support; broker non-votes ~4.7M each.
Advisory say-on-pay passed with ~10.1M for vs 0.9M against; ratification of RMS US LLP as auditor passed with ~15.3M for.
Annual meeting held Aug 8, 2024; 15.7M shares voted of 20.6M outstanding.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.